1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

TEI Biosciences

TEI Biosciences


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    1
    Views:
    2,295
  2. anonymous
    Replies:
    0
    Views:
    2,932
  3. Anonymous
    Replies:
    5
    Views:
    3,716
  4. Anonymous
    Replies:
    53
    Views:
    21,073
  5. Anonymous
    Replies:
    14
    Views:
    3,839
  6. Anonymous
    Replies:
    110
    Views:
    36,445
  7. Anonymous
    Replies:
    60
    Views:
    29,231
  8. SheDat
    Replies:
    0
    Views:
    4,307

Thread Display Options

Loading...